SAN DIEGO, July 23, 2015 /PRNewswire/ -- OncoSec Medical
Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing
DNA-based intratumoral cancer immunotherapies, invites investors
and the general public to its Annual Shareholder Meeting at
9:00 AM PT/12:00 PM ET on Friday,
July 31, 2015. The meeting will be held at the following
location: 10996 Torreyana Road, Lighthouse Room, San Diego, California 92121.
A live webcast of the meeting will also be available. Please use
the following link to register for the meeting:
https://engage.vevent.com/rt/oncosecmedicalincorporated~073115. An
archived version of the webcast will be available for 90 days on
OncoSec's website: www.oncosec.com.
To access the Notice of Annual Meeting of Stockholders and Proxy
Statement, which describe the formal business to be conducted at
the meeting, please click here.
About OncoSec Medical Incorporated
OncoSec is a
biopharmaceutical company developing its investigational
ImmunoPulse™ intratumoral cancer immunotherapy. OncoSec's core
technology is designed to enhance the local delivery and uptake of
DNA IL-12 and other DNA-based immune-targeting agents. Clinical
studies of ImmunoPulse™ IL-12 have demonstrated an acceptable
safety profile and evidence of anti-tumor activity in the treatment
of various skin cancers as well as the potential to initiate a
systemic immune response. OncoSec's lead program, ImmunoPulse™
IL-12, is currently in Phase II development for several
indications, including metastatic melanoma and squamous cell
carcinoma of the head and neck. In addition to ImmunoPulse™ IL-12,
the company is also identifying and developing new immune-targeting
agents for use with the ImmunoPulse™ platform. For more
information, please visit www.oncosec.com.
CONTACT:
Investor Relations:
Jordyn Kopin
OncoSec
855-662-6732
investors@oncosec.com
Media Relations:
Mary Marolla
OncoSec
855-662-6732
media@oncosec.com
Logo -
http://photos.prnewswire.com/prnh/20120905/LA68078LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/oncosec-to-webcast-annual-meeting-of-stockholders-300117466.html
SOURCE OncoSec Medical Inc.